Re: Long-term control in a patient with metastatic lung adenocarcinoma after discontinuation of nivolumab
J Oncol Pharm Pract
.
2021 Jun;27(4):1052.
doi: 10.1177/10781552211004680.
Epub 2021 Mar 27.
Authors
R Pampín-Sánchez
1
,
F J Barbazán-Vázquez
1
,
B Fernández-González
1
,
B Rodríguez-de-Castro
1
,
C Aparicio-Carreño
1
,
T Sampedro-Gimeno
2
Affiliations
1
Department of Pharmacy, Hospital Universitario Cabueñes, Asturias, Spain.
2
Oncology Department, Hospital Universitario Cabueñes, Asturias, Spain.
PMID:
33779367
PMCID:
PMC8193621
DOI:
10.1177/10781552211004680
No abstract available
Publication types
Letter
MeSH terms
Adenocarcinoma of Lung* / drug therapy
Humans
Lung Neoplasms* / drug therapy
Nivolumab / therapeutic use
Substances
Nivolumab